TP53 and hepatocellular carcinoma: A groundbreaking study that exploited a chimeric HCC mouse model, in which p53-deficient embryonic hepatoblasts were transduced with an oncogenic Ras and injected into the livers of athymic mice, has elegantly illustrated that reactivating endogenous p53 results in a robust senescence response and tumor regression [87].